Liver is the largest solid organ in the body that performs over 100 functions. It removes the
toxins and waste products from the blood stream, maintains healthy blood sugar levels …

Hepatocellular Carcinoma (HCC) is a highly aggressive cancer with mortality running
parallel to its incidence and has limited therapeutic options. Chronic liver inflammation and …

Cancer is a major public health problem worldwide. Gastrointestinal cancers account for
approximately one-third of the total global cancer incidence and mortality. Historically, the …

Hepatocellular carcinoma (HCC) is a chronic liver disease that is highly fatal if not detected
and treated early. The incidence and death rate of HCC have been increasing in recent …

Simple Summary The study investigates the potential use of metformin, a medication
commonly prescribed for type 2 diabetes, in the treatment of hepatocellular carcinoma …

Background: Systemic therapy for hepatocellular carcinoma (HCC) consisting of the tyrosine
kinase inhibitor sorafenib has remained unchanged for over a decade, although results from …

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality
worldwide and accounts for 90% of all primary liver cancers. Chronic inflammation is the …

LOXL2, a copper-dependent amine oxidase, has emerged as a promising therapeutic target
in hepatocellular carcinoma (HCC). Increased LOXL2 expression in HCC has been linked …

Hepatocellular carcinoma (HCC) is one of the most common malignancies with high
mortality and morbidity rates. In recent years, HCC targeted therapy has gained increasing …

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer with a
poor prognosis and limited therapeutic options. Alpha-fetoprotein (AFP), an established …